Adverum Biotechnologies, Inc. ADVM

1 patient of 36 had an adverse reaction 30 weeks later....? Already suffering from a degenerative eye disease...? Yeah, I’ll take the bet this was not caused by the trial.

Buy their fear! Extreme over reaction pushed further by shorts.

There was close to 100k short at $4.10 5 minutes ago. All gone

Shorts in here heavy now. A little buying pressure will sort them out

Just a reminder, the patients on trial were losing their eyesight to begin with, hence the trial. ?

I love all the doctors here. Yeah someone lost vision. You have no evidence at this time to say the loss of vision was due to the trial....

1 person, trail was 30 months ago? No way this is connected. In at $4.01

History $IBIO was built for pandemic purposes in 2010 by DARPA. In 2011 the influenza disease outbreak happened and IBIO hit their peak as a company. Then the disease died out and so did their stock price. In 2014, the outbreak of Ebola happened and so they hit another peak. Now look where we’re at now.Covid is destroying the world in many ways and people are seeing how big this has effected the world so far. IBIO was built for this exact reason. In my opinion, influenza became less dangerous as scientists have developed vaccines and the spread of Ebola died out. COVID will not die for months/years to come. $IBIO shares price in past pandemics 15$-55$, $IBIO is known for FastPharming has applications far beyond producing a COVID-19 vaccine. An example of this potential was a deal signed in October with Safi Biosolutions. The agreement will see iBio’s FastPharming system used in the bioprocessing of Safi’s blood cell therapy products. FastPharming has the potential to be part of many such deals in the future. $IBIO conference is Today (there are speculation of possible contract or partnership)